Helix BioPharma Corp. (TSX:HBP)
Canada · Delayed Price · Currency is CAD 1.870
+0.070 (3.89%)
Aug 14, 2026, 2:47 PM EST
Helix BioPharma Cash Flow Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Net Income | -3.32 | -5.21 | -9.26 | -6.29 | -6.56 | -8.04 |
Depreciation & Amortization | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.2 |
Loss (Gain) From Sale of Assets | - | -0.02 | - | -0.01 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -1.54 |
Stock-Based Compensation | 0.02 | 0.18 | 3.52 | 0.57 | 0.43 | 0.66 |
Other Operating Activities | 0.1 | -0.13 | 0.03 | 0 | 0.51 | 0.09 |
Change in Accounts Receivable | -0.01 | -0.07 | 0.01 | 0.22 | 0.07 | -0.17 |
Change in Accounts Payable | -0.13 | 1.3 | 0.67 | -0.07 | -0.87 | 0.05 |
Change in Other Net Operating Assets | 0.13 | 0.1 | -0.19 | 0.04 | -0.1 | 0.07 |
Operating Cash Flow | -3.21 | -3.83 | -5.22 | -5.53 | -6.51 | -9.3 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Capital Expenditures | - | -0 | -0.01 | -0.01 | - | - |
Sale of Property, Plant & Equipment | - | 0.02 | - | 0.01 | - | - |
Divestitures | - | - | - | - | - | 2.02 |
Investing Cash Flow | - | 0.02 | -0.01 | -0.01 | - | 2.02 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Long-Term Debt Issued | - | - | - | - | - | 3.16 |
Long-Term Debt Repaid | - | - | - | -2.06 | - | -0.16 |
Net Debt Issued (Repaid) | - | - | - | -2.06 | - | 3 |
Issuance of Common Stock | 5.32 | 2.8 | 5.51 | 5.63 | 6.21 | 3.56 |
Other Financing Activities | - | - | - | -0.48 | - | - |
Financing Cash Flow | 5.32 | 2.8 | 5.51 | 3.09 | 6.21 | 6.56 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | - | -0.01 | 0.05 |
Net Cash Flow | 2.11 | -1.02 | 0.27 | -2.44 | -0.31 | -0.67 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Free Cash Flow | -3.21 | -3.83 | -5.23 | -5.54 | -6.51 | -9.3 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.04 | -0.07 | -0.12 | -0.14 | -0.22 | -0.34 |
Levered Free Cash Flow | 2.04 | -1.86 | -2.75 | -2.2 | -4.24 | -4.8 |
Unlevered Free Cash Flow | 2.06 | -1.85 | -2.74 | -2.19 | -4.23 | -4.79 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Cash Income Tax Paid | - | -0.01 | - | - | - | - |
Change in Working Capital | -0.01 | 1.33 | 0.49 | 0.19 | -0.89 | -0.05 |